PGNY News and Press, Progyny Inc. From 02/27/23

Reports Full Year Revenue of $786.9 Million, Reflecting 57% Growth Reports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, Respectively Issues Financial Guidance for 2023, Anticipates Crossing $1 Billion Revenue Milestone NEW YORK, Feb. 27, 2023 (GLOB...

Progyny ( NASDAQ: PGNY ) is scheduled to announce Q4 earnings results on Monday, February 27th, after market close. The consensus EPS Estimate is $0.02 (-86.7% Y/Y) and the consensus Revenue Estimate is $211.78M (+66.0% Y/Y). Over the last 1 year, PGNY has beaten EPS estimat...

Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund (the “Fund”) was up 4.24% (Institutional Shares) in the fourth quarter of 2022. ...

NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period and full year ended December 31, 2022 after the close of the...

MONSEY, N.Y., Feb. 07, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Progyny, Inc. (Nasdaq: PGNY) (“Progyny”) has violated federal securities laws based on a new report by Spruce Point Capital Management alleging improper revenue recogniti...

Summary There is a lack of effective solution in standard fertility benefit packages and PGNY is addressing this gap. PGNY's approach drives down the overall cost. I expect revenue to continue growing strongly despite the weak macro. Thesis highlight Progyny ( PGNY ...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Markets returned to positive territory in the fourt...

Anticipates Results to be at the High-End of its Previously Provided Financial Guidance Anticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the ...

Summary Compared to many newly listed public companies in recent years, Progyny is thriving as client count and revenues have grown tremendously. Progyny is the market leader in the fertility benefits arena, with a proven and successful management team. With flexible and unmatched f...

Summary Progyny is the only fertility company to gather and publish data about treatment outcomes, which leads to better clinical results compared to the competition. Progyny's superior solutions enable the company to develop a strong brand awareness as it is demonstrated by the company...